找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Research: An Interdisciplinary Approach; Nima Rezaei Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive lic

[復(fù)制鏈接]
樓主: Taft
41#
發(fā)表于 2025-3-28 17:09:40 | 只看該作者
42#
發(fā)表于 2025-3-28 20:44:56 | 只看該作者
43#
發(fā)表于 2025-3-29 00:10:33 | 只看該作者
Lecture Notes in Computer Scienceters. Many patients with IEI may benefit from pre-emptive HSCT to decrease the risk of malignancy or if they have had a previously treated malignancy, HSCT may reduce the risk of a second malignancy..This review will outline successes in the field of HSCT for IEI, and specifically consider HSCT in t
44#
發(fā)表于 2025-3-29 03:45:34 | 只看該作者
45#
發(fā)表于 2025-3-29 09:02:12 | 只看該作者
https://doi.org/10.1007/978-3-642-39931-2mmation may pave the link between depression and cancer development. We discuss the link between depression and malignant cell transformation considering common molecular mechanisms of inflammation that underpins this plausible association. The complexity of dopaminergic pathways involved in the reg
46#
發(fā)表于 2025-3-29 14:35:29 | 只看該作者
Modelling Legitimate Expectationsthway that is easy to translate into clinical practice are highlighted. Given the growing evidence of the clinical importance of the muscle-immune system in cancer patients, early recognition and intervention of sarcopenia would be able to restore both skeletal muscle and immune system function and
47#
發(fā)表于 2025-3-29 18:03:25 | 只看該作者
2731-4561 ing on cell biology, immunology, hematology, biochemistry, genetics, oncology and related fields. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientif978-3-031-32460-4978-3-031-32458-1Series ISSN 2731-4561 Series E-ISSN 2731-457X
48#
發(fā)表于 2025-3-29 22:11:59 | 只看該作者
49#
發(fā)表于 2025-3-30 00:11:56 | 只看該作者
Role of Immune Cells in the Tumor Microenvironment, immune cells by using various mechanisms..Various immunotherapy treatments have been developed and applied to patients based on immune eradication mechanisms. Contrary to traditional chemotherapy, immunotherapy destroys cancer cells by harnessing the immune cells within or outside the TME. Immune c
50#
發(fā)表于 2025-3-30 07:59:01 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 19:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南昌县| 惠东县| 永靖县| 石棉县| 祁阳县| 潮安县| 宜春市| 荥阳市| 奎屯市| 乐安县| 抚宁县| 虞城县| 江山市| 临沂市| 武威市| 潢川县| 张掖市| 嘉祥县| 石城县| 湘西| 徐闻县| 锡林郭勒盟| 石首市| 察隅县| 禹城市| 平阴县| 霸州市| 增城市| 镇沅| 林西县| 林州市| 武穴市| 阳谷县| 扬州市| 札达县| 新竹县| 阿巴嘎旗| 云浮市| 邓州市| 临泉县| 龙泉市|